M F R I Inc (MFRI) 7.65 $MFRI Shares of MFRI Up 36.2%

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
M F R I Inc (MFRI) 7.65 $MFRI

Shares of MFRI Up 36.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 07, 1:15PM CDT
SmarTrend identified an Uptrend for Mfri (NASDAQ:MFRI) on October 8th, 2015 at $5.46. In approximately 9 months, Mfri has returned 36.21% as of today's recent price of $7.43.
MFRI: 7.65 (+0.12)

Mfri Shares Up 39.7% Since SmarTrend's Buy Recommendation (MFRI)
Comtex SmarTrend(R) - Wed Jun 22, 1:13PM CDT
SmarTrend identified an Uptrend for Mfri (NASDAQ:MFRI) on October 8th, 2015 at $5.46. In approximately 9 months, Mfri has returned 39.69% as of today's recent price of $7.62.
MFRI: 7.65 (+0.12)

Uptrend Call Working As Mfri Stock Rises 34.4% (MFRI)
Comtex SmarTrend(R) - Wed Jun 15, 1:02AM CDT
SmarTrend identified an Uptrend for Mfri (NASDAQ:MFRI) on October 8th, 2015 at $5.46. In approximately 8 months, Mfri has returned 34.37% as of today's recent price of $7.33.
MFRI: 7.65 (+0.12)

MFRI Announces First Quarter Fiscal 2016/17 Financial Results
Marketwired - Fri Jun 10, 4:08PM CDT
Net Sales Rise 14% in the Quarter, Largely Due to Inclusion of Revenue From New Canadian Subsidiary; Pretax Loss of $4.5 Million Includes $0.6 Million Increase in Operating Expenses From Expenses Related to Canadian Subsidiary, Professional Service Fees for Transactions and Severance Costs, and $0.4 Million Margin Reduction From Prior-Year Quarter; Net Loss of $6.3 million, or $0.86 per Diluted Share, Includes $1.6 Million Non-Cash Expense for Adjustment to Carried Value of 49% Interest in BPPC; Working to Expand Scope of Piping Offerings in North America and Middle East
MFRI: 7.65 (+0.12)

45.2% Return Seen to Date on SmarTrend Mfri Call (MFRI)
Comtex SmarTrend(R) - Tue Jun 07, 1:04PM CDT
SmarTrend identified an Uptrend for Mfri (NASDAQ:MFRI) on October 8th, 2015 at $5.46. In approximately 8 months, Mfri has returned 45.19% as of today's recent price of $7.92.
MFRI: 7.65 (+0.12)

Shares of MFRI Up 44.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue May 31, 12:25AM CDT
SmarTrend identified an Uptrend for Mfri (NASDAQ:MFRI) on October 8th, 2015 at $5.46. In approximately 8 months, Mfri has returned 44.45% as of today's recent price of $7.88.
MFRI: 7.65 (+0.12)

Mfri Has Returned 37.3% Since SmarTrend Recommendation (MFRI)
Comtex SmarTrend(R) - Mon May 23, 1:07PM CDT
SmarTrend identified an Uptrend for Mfri (NASDAQ:MFRI) on October 8th, 2015 at $5.46. In approximately 8 months, Mfri has returned 37.30% as of today's recent price of $7.49.
MFRI: 7.65 (+0.12)

Mfri Has Returned 22.9% Since SmarTrend Recommendation (MFRI)
Comtex SmarTrend(R) - Fri May 13, 1:23PM CDT
SmarTrend identified an Uptrend for Mfri (NASDAQ:MFRI) on October 8th, 2015 at $5.46. In approximately 7 months, Mfri has returned 22.91% as of today's recent price of $6.71.
MFRI: 7.65 (+0.12)

Mfri Up 28.3% Since SmarTrend Uptrend Call (MFRI)
Comtex SmarTrend(R) - Fri May 06, 12:43AM CDT
SmarTrend identified an Uptrend for Mfri (NASDAQ:MFRI) on October 8th, 2015 at $5.46. In approximately 7 months, Mfri has returned 28.32% as of today's recent price of $7.00.
MFRI: 7.65 (+0.12)

MFRI Announces Fourth Quarter and Full Year Financial Results
Marketwired - Thu Apr 28, 4:15PM CDT
MFRI, Inc. (NASDAQ: MFRI) announced today financial results for the fourth quarter and fiscal year ended January 31, 2016.
MFRI: 7.65 (+0.12)

Shares of MFRI Up 28.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 21, 1:34PM CDT
SmarTrend identified an Uptrend for Mfri (NASDAQ:MFRI) on October 8th, 2015 at $5.46. In approximately 7 months, Mfri has returned 28.32% as of today's recent price of $7.00.
MFRI: 7.65 (+0.12)

BGL Advises on MFRI Filtration Business Divestitures Spanning Three Continents
PR Newswire - Wed Mar 23, 6:21AM CDT
Brown Gibbons Lang & Company (BGL), is pleased to announce the simultaneous sales of the United States, European, and Middle East filtration businesses of MFRI, Inc. (NASDAQ: MFRI) to CLARCOR Inc. (NYSE: CLC) and Hengst Holdings GmbH. The businesses manufacture pleated air filter bags and dust collection cartridges for a broad range of industrial manufacturing and process end markets to meet and achieve environmental and workplace safety requirements. The businesses also manufacture gas turbine air inlet filters that protect gas turbine blades and equipment. BGL served as the exclusive financial advisor to MFRI in the divestitures, and the transactions are representative of BGL's global industrial transaction capabilities and reach.
MFRI: 7.65 (+0.12), CLC: 62.26 (-0.39)

36.4% Return Seen to Date on SmarTrend Mfri Call (MFRI)
Comtex SmarTrend(R) - Mon Feb 08, 4:05PM CST
SmarTrend identified an Uptrend for Mfri (NASDAQ:MFRI) on October 8th, 2015 at $5.46. In approximately 4 months, Mfri has returned 36.39% as of today's recent price of $7.44.
MFRI: 7.65 (+0.12)

Aegion Corporation Completes the Sale of Bayou Perma-Pipe Canada, Ltd for USD $9.6 Million
BusinessWire - Thu Feb 04, 2:20PM CST
Aegion Corporation (Nasdaq Global Select Market: AEGN) today completed the sale of its 51 percent interest in Bayou Perma-Pipe Canada, Ltd, a pipe coating company in Western Canada, to its joint venture partner, MFRI, Inc., for USD $9.6 million. The Company also expects to complete its company-wide cost reduction initiative and close the acquisition of Underground Solutions, Inc. in the coming weeks.
MFRI: 7.65 (+0.12), AEGN: 20.52 (-0.01)

MFRI Announces Actions to Advance Strategic Positioning Through Focus on Piping Businesses
Marketwired - Mon Feb 01, 8:01AM CST
MFRI, Inc. (NASDAQ: MFRI) today announced a series of actions designed to refocus its business portfolio and cost structure to enhance the Company's overall performance. These actions include the sale of MFRI's domestic and international filtration businesses, including TDC Filter Manufacturing, Inc., Nordic Air Filtration, A/S and related assets, and the planned sale of our domestic fabric filter business in Winchester, Virginia. The sales follow a competitive bidding process that MFRI initiated as part of its program to optimize its strategic focus and portfolio.
MFRI: 7.65 (+0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 21

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 7

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 24

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 25

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 15

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 22

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 33

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 16

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 7

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading

Top 5 Most Recently Viewed Articles

Pieridae Energy Limited Reports Strong Q3 2024 Performance

Updated Category News Views 58

Strong Financial and Operational Results from Pieridae Energy CALGARY, Alberta - Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) has announced its third quarter 2024 financial and operating results, showcasing an impressive production output and robust financial performance. The company achieved a production rate of 23,116 barrels of oil...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 136

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
Study Confirms Safety of Combined Eye Drops for Surgery Use

Updated Category News Views 172

Introduction to the Study A five-year pharmacovigilance study has confirmed the excellent safety profile of a fixed-dose combination eye drop developed by NTC. This eye drop combines an anti-inflammatory steroid and a quinolone antibiotic, designed for preventing and treating inflammation, as well as preventing infection after cataract surgery. Study Overview The findings...

Continue Reading
New Concerns Arise for Roblox Amid Allegations of Misreported Metrics

Updated Category News Views 203

Allegations Against Roblox: A Closer Look Roblox Corp (NYSE: RBLX) has recently come under fire after a report from Hindenburg Research highlighted potential discrepancies in its reported user metrics, leading to a notable decline in its stock prices. The gaming platform is being questioned for allegedly overstating its user metrics, including daily active users (DAUs)...

Continue Reading
uniQure N.V. Faces Investigation Amid Securities Fraud Concerns

Updated Category News Views 155

Understanding the uniQure N.V. Investigation Currently, uniQure N.V. is under investigation concerning possible violations of securities laws. This inquiry has raised significant concerns for shareholders and potential investors, driving many to seek assistance in understanding their rights moving forward. The investigation is being led by the DJS Law Group, an...

Continue Reading